Bruce J. Seeley
2019 - CTI BioPharma
In 2019, Bruce J. Seeley earned a total compensation of $859.5K as Executive Vice President, Chief Operating Officer at CTI BioPharma, a 24% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $185,812 |
|---|---|
| Option Awards | $244,640 |
| Salary | $420,629 |
| Other | $8,400 |
| Total | $859,481 |
Seeley received $420.6K in salary, accounting for 49% of the total pay in 2019.
Seeley also received $185.8K in non-equity incentive plan, $244.6K in option awards and $8.4K in other compensation.
Rankings
In 2019, Bruce J. Seeley's compensation ranked 9,938th out of 13,971 executives tracked by ExecPay. In other words, Seeley earned more than 28.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,938 out of 13,971 | 29th |
Division Manufacturing | 4,015 out of 5,701 | 30th |
Major group Chemicals And Allied Products | 1,526 out of 2,200 | 31st |
Industry group Drugs | 1,305 out of 1,886 | 31st |
Industry Pharmaceutical Preparations | 970 out of 1,398 | 31st |
Source: SEC filing on April 23, 2020.
Seeley's colleagues
We found two more compensation records of executives who worked with Bruce J. Seeley at CTI BioPharma in 2019.